What is AL-LAD?
AL-LAD, referred to technically as 6-Allyl-6-nor-lysergic acid diethylamide, is a relatively novel analogue of LSD-25. It is presumed to have a similar mechanism of action, working primarily by binding to the brain’s serotonin receptors. It is also thought to be a prodrug of LSD-25, though this has not been confirmed in a lab setting.
How is AL-LAD different to LSD?
AL-LAD is often referred to as the most “recreational” of the lysergamide analogues. It is noted for it’s heightened visual hallucinations and its relatively mild psychological effects when compared to 1P-LSD and LSD-25. Users generally report lower levels of anxiety and over-thinking when compared to other lysergamides. However, this does not mean that AL-LAD cannot severely affect cognitive ability and a user’s psychological state, especially at higher doses.
A Brief History of AL-LAD
The earliest mentions of AL-LAD are from an investigation in 1984 done by Andrew J. Hoffman and David Nichols as part of a series of LSD analogs, which also included ETH-LAD and PRO-LAD. Its activity in humans was later documented by Alexander Shulgin in his book TiHKAL (“Tryptamines I Have Known and Loved”), in which it is described as “considerably less dramatic”, which correlates with many reports from users. In 2013, AL-LAD appeared for sale on the research chemical market, where it has been commonly marketed alongside lysergamides such as 1P-LSD, ALD-52 and ETH-LAD as a legal, grey-market alternative to LSD.
AL-LAD was very difficult to find on the market for several years as the synthesis of it is very difficult without using LSD-25, which would make the production of it illegal. Luckily, in 2020 (one of the few positive things to come of that year!) a Netherlands based laboratory was able to find a route to synthesising it without the use of LSD, bringing the much loved compound backed onto the market.
What are the Effects of AL-LAD?
Al-LAD is often reported as having some distinct differences from LSD and other lysergamides and it is generally seen as a suitable “introductory” psychedelic for more novice researchers.
The key differences between AL-LAD and other lysergamides are:
- Enhanced visuals – AL-LAD is known to produce more acute visual effects, even at dosages that don’t greatly impact the users mental cognition.
- Lighter head space – AL-LAD is also known to have relatively mild psychological effects (such as anxiety, thought-loops, overthinking etc) when compared to other lysergamides.
- Euphoria – AL-LAD is also often seen to produce greater feelings of euphoria
- Bodyload – some researchers report greater than usual bodyload when experimenting with AL-LAD
Some of the most commonly reported effects of AL-LAD are:
- Spontaneous bodily sensations
- Physical euphoria
- Visual hallucinations
- Increased music appreciation
- Colour enhancement
- Fits of laughter and increased sense of humour
- Cognitive euphoria
Potential Side Effects of AL-LAD
- Muscle contractions
- Increased heart rate
- Excessive yawning
- Increased salivation
- Pupil dilation
AL-LAD is classified as illegal in:
- United Kingdom
This list is not exhaustive, so do your own research into the legal status in your country before ordering!
All products are strictly for research purposes only and not for human consumption.
Store in a cool, dry place away from sunlight. Lysergamides and Tryptamines should be kept below 20'c where possible
FREE EXCLUSIVE PRODUCT INFO CHEMCARD WITH EVERY ORDER!!
Printed on premium card with copper foil inlay, soft-touch lamination, and custom artwork.
Have a look at them here.
Product Name: AL-LAD 150mcg Blotters
Other Name(s): 6-allyl-6-nor-LSD
Active Ingredient(s): AL-LAD (150 mcg)
Other Ingredient(s): Soy based ink, 200 gsm blotting paper